Skip to main content
Free access
Research Article
1 August 2019

Facilitators and barriers to successful recruitment into a large comparative effectiveness trial: a qualitative study

Abstract

Background: Recruitment of participants into research studies, especially individuals from minority groups, is challenging; lack of diversity may lead to biased findings. Aim: To explore beliefs about research participation among individuals who were approached and eligible for the GRADE study. Methods: In-depth qualitative telephone interviews with randomized participants (n = 25) and eligible individuals who declined to enroll (n = 26). Results: Refusers and consenters differed in trust and perceptions of risk, benefits and burden of participation. Few participants understood how comparative effectiveness research differed from other types of trials; however, some features of comparative effectiveness research were perceived as lower risk. Conclusion: We identified facilitators and addressable barriers to participation in research studies.

Supplementary Material

File (final grade research group_2019.05.30.pdf)

References

1.
Paramasivan S, Huddart R, Hall E, Lewis R, Birtle A, Donovan JL. Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011). Trials 12(1), 78 (2011).
2.
Paskett ED, Reeves KW, McLaughlin JM et al. Recruitment of minority and underserved populations in the United States: the centers for population health and health disparities experience. Contemp. Clin. Trials 29(6), 847–861 (2008).
3.
Durant RW, Wenzel JA, Scarinci IC et al. Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT). Cancer 120(Suppl. 7), 1097–1105 (2014).
4.
Ford ME, Siminoff LA, Pickelsimer E et al. Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health Soc. Work 38(1), 29–38 (2013).
5.
George S, Duran N, Norris K. A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am. J. Public Health 104(2), e16–e31 (2013).
6.
Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J. Gen. Intern. Med. 14(9), 537–546 (1999).
7.
Coakley M, Fadiran EO, Parrish LJ, Griffith RA, Weiss E, Carter C. Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials. J. Womens Health 2002 21(7), 713–716 (2012).
8.
Shavers VL, Lynch CF, Burmeister LF. Knowledge of the Tuskegee study and its impact on the willingness to participate in medical research studies. J. Natl Med. Assoc. 92(12), 563–572 (2000).
9.
Yancey AK, Ortega AN, Kumanyika SK. Effective recruitment and retention of minority research participants. Annu. Rev. Public Health 27, 1–28 (2006).
10.
Wisdom K, Neighbors K, Williams VH, Havstad SL, Tilley BC. Recruitment of African Americans with Type 2 diabetes to a randomized controlled trial using three sources. Ethn. Health 7(4), 267–278 (2002).
11.
Hoel AW, Kayssi A, Brahmanandam S, Belkin M, Conte MS, Nguyen LL. Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials. J. Vasc. Surg. 50(2), 349–354 (2009).
12.
Cottler LB, McCloskey DJ, Aguilar-Gaxiola S et al. Community needs, concerns, and perceptions about health research: findings from the Clinical and Translational Science Award Sentinel Network. Am. J. Public Health 103(9), 1685–1692 (2013).
13.
Friedly J, Bauer Z, Comstock B et al. Challenges conducting comparative effectiveness research: the Clinical and Health Outcomes Initiative in Comparative Effectiveness (CHOICE) experience. Comp. Eff. Res. 2014(4), 1–12 (2014).
14.
Nathan DM, Buse JB, Kahn SE et al. Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE). Diabetes Care 36(8), 2254–2261 (2013).
15.
Tricoci P. Scientific evidence underlying the ACC/AHA Clinical Practice Guidelines. JAMA 301(8), 831 (2009).
16.
SocioCultural Research Consultants, LLC. 2016, Dedoose version 7.5.9. www.dedoose.com
17.
Eaves YD. A synthesis technique for grounded theory data analysis. J. Adv. Nurs. 35(5), 654–663 (2001).
18.
Mfutso-Bengo J, Masiye F, Molyneux M, Ndebele P, Chilungo A. Why do people refuse to take part in biomedical research studies? Evidence from a resource-poor area. Malawi Med. J. 20(2), 57–63 (2008).
19.
Wade T, Tiggemann M, Martin NG, Heath AC. Characteristics of interview refusers: women who decline to participate in interviews relating to eating. Int. J. Eat. Disord. 22(1), 95–99 (1997).
20.
Underhill K, Morrow KM, Operario D, Mayer KH. Could FDA approval of pre-exposure prophylaxis make a difference? A qualitative study of PrEP acceptability and FDA perceptions among men who have sex with men. AIDS Behav. 18(2), 241–249 (2014).
21.
Baquet CR, Henderson K, Commiskey P, Morrow JN. Clinical trials: the art of enrollment. Semin. Oncol. Nurs. 24(4), 262–269 (2008).
22.
Kerath SM, Klein G, Kern M et al. Beliefs and attitudes towards participating in genetic research – a population based cross-sectional study. BMC Public Health 13(1), (2013). http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-13-114
23.
Gayet-Ageron A, Rudaz S, Perneger T. Biobank attributes associated with higher patient participation: a randomized study. Eur. J. Hum. Genet. 25(1), 31–36 (2016).
24.
Skaff MM, Chesla CA, de los Santos Mycue V, Fisher L. Lessons in cultural competence: adapting research methodology for Latino participants. J. Community Psychol. 30(3), 305–323 (2002).
25.
Froelicher ES, Miller NH, Buzaitis A et al. The Enhancing Recovery in Coronary Heart Disease Trial (ENRICHD): strategies and techniques for enhancing retention of patients with acute myocardial infarction and depression or social isolation. J. Cardpulm. Rehabil. 23(4), 269–280 (2003).
26.
Staffileno BA, Coke LA. Recruiting and retaining young, sedentary, hypertension-prone African American women in a physical activity intervention study. J. Cardiovasc. Nurs. 21(3), 208–216 (2006).
27.
Tilley BC, Mainous AG, Smith DW et al. Design of a cluster-randomized minority recruitment trial: RECRUIT. Clin. Trials 14(3), 286–298 (2017).
28.
Mainous AG. Development of a measure to assess patient trust in medical researchers. Ann. Fam. Med. 4(3), 247–252 (2006).
29.
Brandon DT, Isaac LA, LaVeist TA. The legacy of Tuskegee and trust in medical care: is Tuskegee responsible for race differences in mistrust of medical care? J. Natl Med. Assoc. 97(7), 951–956 (2005).
30.
Scharff DP, Mathews KJ, Jackson P, Hoffsuemmer J, Martin E, Edwards D. More than Tuskegee: understanding mistrust about research participation. J. Health Care Poor Underserved 21(3), 879–897 (2010).
31.
Klonoff EA, Landrine H. Do blacks believe that HIV/AIDS is a government conspiracy against them? Prev. Med. 28(5), 451–457 (1999).
32.
Ejiogu N, Norbeck JH, Mason MA, Cromwell BC, Zonderman AB, Evans MK. Recruitment and retention strategies for minority or poor clinical research participants: lessons from the healthy aging in neighborhoods of diversity across the life span study. Gerontologist 51(Suppl. 1), S33–S45 (2011).
33.
Allen NA, Zagarins SE, Feinberg RG, Welch G. Treating psychological insulin resistance in Type 2 diabetes. J. Clin. Transl. Endocrinol. 7, 1–6 (2017).
34.
Larkin ME, Capasso VA, Chen C-L et al. Measuring psychological insulin resistance. Diabetes Educ. 34(3), 511–517 (2008).
35.
Taylor CG, Taylor G, Atherley A, Hambleton I, Unwin N, Adams OP. The Barbados Insulin Matters (BIM) study: barriers to insulin therapy among a population-based sample of people with Type 2 diabetes in the Caribbean island of Barbados. J. Clin. Transl. Endocrinol. 8, 49–53 (2017).